Glucose-6-phosphate dehydrogenase deficiency.

Area of Science:

• Biochemistry
• Genetics
• Human Physiology

Background:

• Glucose-6-phosphate dehydrogenase (G6PD) is crucial for the pentose phosphate pathway in all tissues.
• G6PD deficiency is widespread globally, particularly in tropical/subtropical regions, due to its protective effect against malaria.
• While often asymptomatic, G6PD deficiency can lead to neonatal jaundice and acute hemolytic anemia (favism) or chronic non-spherocytic hemolytic anemia in severe cases.

Purpose of the Study:

• To summarize the biochemical and genetic aspects of Glucose-6-phosphate dehydrogenase (G6PD) deficiency.
• To highlight the clinical manifestations and evolutionary significance of G6PD deficiency.
• To describe the structural basis of G6PD variants.

Main Methods:

• Literature review of G6PD deficiency prevalence, clinical impact, and genetic basis.
• Analysis of DNA sequences to identify causative mutations in G6PD deficiency variants.
• Structural analysis of G6PD to understand its functional domains.

Main Results:

• G6PD deficiency is prevalent in malaria-endemic areas, conferring a survival advantage.
• Clinical severity ranges from asymptomatic to severe hemolytic anemia, triggered by specific exposures.
• Genetic analysis reveals most G6PD variants arise from single amino acid substitutions.
• Structural studies identified key domains in G6PD, including a novel dimerization domain.

Conclusions:

• G6PD deficiency presents a complex interplay between genetic variation, evolutionary advantage, and clinical risk.
• Understanding G6PD variants at a molecular and structural level is key to managing associated hemolytic conditions.
• Further research into G6PD structure-function relationships can inform therapeutic strategies.